![Andrew Hamer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Hamer
Directeur Technique/Scientifique/R&D chez
CARDIOL THERAPEUTICS INC.
Fortune : 850 833 $ au 31/07/2026
Profil
Andrew Hamer is Chief Medical Officer, Head-Research & Development at Cardiol Therapeutics, Inc. since 2021.
Formerly, Dr. Hamer was Executive Director-Global Development at Amgen, Inc. from 2018 to 2021.
Dr. Hamer was Vice President-Medical Affairs at Capricor Therapeutics, Inc. from 2013 to 2015 and also held the position of Vice President-Medical Affairs at Capricor, Inc. Dr. Hamer completed undergraduate education at the University of Otago.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/12/2025 | 669 947 ( 0,58 % ) | 850 833 $ | 31/07/2026 |
Postes actifs de Andrew Hamer
| Sociétés | Poste | Début |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 29/03/2021 |
Anciens postes connus de Andrew Hamer
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/03/2021 |
| CAPRICOR THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 30/07/2015 |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Provides cardiac stem cell therapeutics biotechnology services | Directeur Technique/Scientifique/R&D | - |
Formation de Andrew Hamer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Provides cardiac stem cell therapeutics biotechnology services | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Cardiol Therapeutics, Inc.
 Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease | Health Technology |
